Long-Term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Chronic Lymphocytic Leukemia (CLL): 10-Year Follow-up of the Gcllsg CLL3X Trial

Kramer Isabelle; Stilgenbauer Stephan; Dietrich Sascha; Bottcher Sebastian; Ritgen Matthias; Bunjes Donald; Zeis Matthias; Stadler Michael; Bittenbring Joerg Thomas; Hegenbart Ute; Hallek Michael; Kneba Michael; Schmitz Norbert; Dohner Hartmut; Dreger Peter

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Long-Term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Chronic Lymphocytic Leukemia (CLL): 10-Year Follow-up of the Gcllsg CLL3X Trial

【24h】

Long-Term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Chronic Lymphocytic Leukemia (CLL): 10-Year Follow-up of the Gcllsg CLL3X Trial

机译：异基因造血干细胞移植（HSCT）治疗慢性淋巴细胞性白血病（CLL）的长期结果：Gcllsg CLL3X试验的10年随访

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2016年第22期|共6页
作者
Kramer Isabelle; Stilgenbauer Stephan; Dietrich Sascha; Bottcher Sebastian; Ritgen Matthias; Bunjes Donald; Zeis Matthias; Stadler Michael; Bittenbring Joerg Thomas; Hegenbart Ute; Hallek Michael; Kneba Michael; Schmitz Norbert; Dohner Hartmut; Dreger Peter;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Long-Term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Chronic Lymphocytic Leukemia (CLL): 10-Year Follow-up of the Gcllsg CLL3X Trial [J] . Kramer Isabelle, Stilgenbauer Stephan, Dietrich Sascha, Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：异基因造血干细胞移植（HSCT）治疗慢性淋巴细胞性白血病（CLL）的长期结果：Gcllsg CLL3X试验的10年随访
2. Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia: results from the GCLLSG CLL3X trial [J] . M Ritgen, S B?ttcher, S Stilgenbauer, Leukemia . 2008,第7期

机译：定量MRD监测可发现异基因干细胞移植后慢性淋巴细胞白血病的不同GVL反应模式：GCLLSG CLL3X试验的结果
3. Impact of telomere length on the outcome of allogeneic stem cell transplantation for poor-risk chronic lymphocytic leukaemia: results from the GCLLSG CLL3X trial [J] . Scheffold Annika, Jebaraj Billy Michael Chelliah, Jaramillo Sonia, British Journal of Haematology . 2017,第2期

机译：端粒长度对贫瘠风险慢性淋巴细胞白血病同种异体干细胞移植结果的影响：GCLLSG CLL3X试验结果
4. Chronic Lymphocytic Leukemia (CLL): New Insight on the Pathogenesis of CLL Cell Survival [C] . L. Lagneaux, A. Delforge, M. Dejeneffe, European Haematology Association . 2002

机译：慢性淋巴细胞白血病（CLL）：对CLL细胞生存发病机制的新见解
5. Folate status and risk of relapse following allogeneic hematopoietic cell transplant for chronic myelogenous leukemia. [D] . Robien, Kimberly Ziemer. 2003

机译：异基因造血细胞移植治疗慢性粒细胞白血病后的叶酸状况和复发风险。
6. Assessment of Impact of Human Leukocyte Antigen (HLA) Type on Outcomes of Allogeneic Hematopoietic Stem Cell Transplant for Chronic Lymphocytic Leukemia (CLL) [O] . Brian T. Hill, Kwang Woo Ahn, Zhen-Huan Hu, -1

机译：评估人类白细胞抗原（HLA）类型对异基因造血干细胞移植治疗慢性淋巴细胞性白血病（CLL）结果的影响
7. Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial [O] . Isabelle Krämer, Stephan Stilgenbauer, Sascha Dietrich, 2017

机译：高风险CLL的同种异体造血细胞移植：GCLLSG CLL3X试验的10年随访

Long-Term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Chronic Lymphocytic Leukemia (CLL): 10-Year Follow-up of the Gcllsg CLL3X Trial

著录项

相似文献

相关主题

期刊订阅